throbber
Preparation and Extraction of Insoluble
`(Inclusion-Body) Proteins from
`Escherichia coli
`
`UNIT 6.3
`
`High-level expression of many recombinant proteins in Escherichia coli leads to the
`formation of highly aggregated protein commonly referred to as inclusion bodies
`(UNITS 5.1 & 6.1). Inclusion bodies are normally formed in the cytoplasm; alternatively,
`if a secretion vector is used, they can form in the periplasmic space. Inclusion bodies are
`not restricted to E. coli; they can also form in yeast, mammalian, and insect cells.
`
`Inclusion bodies recovered from cell lysates by low-speed centrifugation are heavily
`contaminated with E. coli cell wall and outer membrane components. The latter are
`largely removed by selective extraction with detergents and low concentrations of either
`urea or guanidine·HCl to produce so-called washed pellets. These basic steps result in a
`significant purification of the recombinant protein, which usually makes up ∼60% of the
`washed pellet protein. The challenge, therefore, is not to purify the recombinant-derived
`protein, but to solubilize it and then fold it into native and biologically active protein.
`
`Basic Protocol 1 describes preparation of washed pellets and solubilization of the protein
`using guanidine·HCl. The extracted protein, which is unfolded, is either directly folded as
`described in UNIT 6.5 or further purified by gel filtration in the presence of guanidine·HCl
`as in Basic Protocol 2. A Support Protocol describes the removal of guanidine·HCl from
`column fractions so they can be monitored by SDS-PAGE (UNIT 10.1).
`
`Other methods discussed in the Commentary section of this unit include the direct purifi-
`cation of polyhistidine-tagged proteins solubilized in guanidine·HCl, preparative removal
`of guanidine·HCl by reversed-phase chromatography as a prelude to protein folding, and
`the solubilization of inclusion bodies with anionic detergents.
`
`PREPARATION AND EXTRACTION OF INSOLUBLE (INCLUSION-BODY)
`PROTEINS FROM ESCHERICHIA COLI
`Bacterial cells are lysed using a French press, and inclusion bodies in the cell lysate are
`pelleted by low-speed centrifugation. The pellet fraction is washed (preextracted) with
`urea and Triton X-100 to remove E. coli membrane and cell wall material. Guanidine·HCl
`(8 M) and dithiothreitol (DTT) are used to solubilize the washed pellet protein. Extraction
`with the denaturant simultaneously dissociates protein-protein interactions and unfolds
`the protein. As a result, the extracted protein consists (ideally) of unfolded monomers,
`with sulfhydryl groups (if present) in the reduced state.
`
`Materials
`
`E. coli cells from fermentation (UNIT 5.3) containing the protein of interest
`Lysis buffer (see recipe)
`Wash buffer (see recipe), with and without urea and Triton X-100
`Extraction buffer (see recipe)
`250- and 500-ml stainless steel beakers
`Waring blender
`Polytron tissue-grinder homogenizer (Brinkmann)
`French pressure cell (e.g., Thermo Electron Corp.; http://www.thermo.com)
`
`Contributed by Ira Palmer and Paul T. Wingfield
`Current Protocols in Protein Science (2004) 6.3.1-6.3.18
`Copyright C(cid:2) 2004 by John Wiley & Sons, Inc.
`
`BASIC
`PROTOCOL 1
`
`Purification of
`Recombinant
`Proteins
`
`6.3.1
`
`Supplement 38
`
`Page 1
`
`KASHIV EXHIBIT 1021
`IPR2019-00791
`
`

`

`Probe sonicator
`Beckman J2-21M centrifuge with JA-14 rotor (or equivalent)
`Beckman Optima XL-90 ultracentrifuge with 45 Ti rotor (or equivalent)
`0.22-µm syringe filters (e.g., Millex from Millipore)
`20-ml disposable syringe
`Additional equipment for breaking cells, homogenizing cells and pellets and
`centrifuging at low and high speeds (UNIT 6.2)
`
`Break cells and prepare clarified lysate
`1. Place thawed E. coli cells in a stainless steel beaker. Add 4 ml lysis buffer per gram
`wet weight of cells. Keep bacterial cells cool by placing the beaker on ice in an ice
`bucket.
`The cells can be pretreated with lysozyme prior to lysis in the French press. Lysozyme
`treatment involves incubating cells −20 min at 20
`◦
`◦
`to 25
`C inlysis buffer supplemented
`with 200 µg/ml lysozyme, with intermittent homogenization using a tissue grinder. It
`should be emphasized that this optional step is carried out before French press breakage
`and is not simply an alternative method of cell breakage (compare the comments made
`in the annotation to step 4 of UNIT 6.2). Its purpose is to aid removal of the peptidoglycan
`and outer membrane protein contaminants during the washing steps (steps 6 to 9; for
`further details see UNIT 6.1 and Fig. 6.1.5). An example of this approach is given in Basic
`Protocol 1 of UNIT 6.5.
`
`For sensitive proteins, replace benzamidine in the lysis buffer by a protease inhibitor
`cocktail that includes five protease inhibitors with broad specificity for the inhibition of
`aspartic proteases, cysteine proteases, serine proteases, and metalloproteases, as well as
`aminopeptidases. These are supplied by various companies including Calbiochem and
`Sigma.
`
`2. Suspend cells using a Waring blender and homogenize using the Polytron tissue-
`grinder homogenizer until all clumps are disrupted, as described in UNIT 6.2,
`step 3.
`
`3. Lyse cells with two passes through the French pressure cell operated at 16,000 to
`18,000 psi (with the high-ratio setting, pressure gauge readings between 1011 and
`◦
`1135), chilling the cell suspension to 4
`C after each pass, as described in UNIT 6.2,
`steps 2 and 4.
`
`4. Reduce the viscosity of the suspension by sonicating 5 min at full power with 50%
`duty cycle (on for 5 sec, off for 5 sec) using an ultrasonic homogenizer, as described
`in UNIT 6.2, step 5.
`5. Clarify the lysed cell suspension by centrifuging 1 hr at 22,000 × g (12,000 rpm in
`◦
`a JA-14 rotor in a Beckman J2-21M centrifuge), 4
`C.
`
`Unbroken cells, large cellular debris, and the inclusion body protein will be pelleted.
`
`The JA-14 rotor uses 250-ml centrifuge bottles. For processing smaller volumes the
`Beckman JA-20 rotor (or equivalent) with 50-ml tubes can be used, at 13,500 rpm
`(22,000 × g).
`The procedure for dealing with insoluble inclusion-body proteins now diverges from that
`for purifying soluble proteins (UNIT 6.2).
`
`Prepare washed pellets
`6. Carefully decant the supernatant from the pellet. Using a tissue homogenizer, suspend
`the pellet with 4 to 6 ml wash buffer per gram wet weight cells.
`
`Complete homogenization of the pellet is important to wash out soluble proteins and
`cellular components. Removal of cell wall and outer membrane material can be improved
`by increasing the amount of wash solution to 10 ml per gram cells.
`
`Current Protocols in Protein Science
`
`Preparation and
`Extraction of
`Inclusion Bodies
`
`6.3.2
`
`Supplement 38
`
`Page 2
`
`

`

`The concentration of urea and Triton X-100 in the wash buffer can be varied. The urea
`concentration is usually between 1 and 4 M; higher concentrations may result in partial
`solubilization of the recombinant proteins. The usual detergent concentration is 0.5% to
`5%. Triton X-100 will not solubilize inclusion body proteins; it is included to help extract
`lipid and membrane-associated proteins.
`7. Centrifuge the suspension 30 min at 22,000 × g (12,000 rpm in JA-14), 4
`C. Discard
`supernatant and, using the tissue homogenizer, suspend the pellet in 4 to 6 ml wash
`buffer per gram wet weight of cells.
`
`◦
`
`8. Repeat step 7 two more times.
`
`If the supernatant is still cloudy or colored, continue washing the pellet until the super-
`natant is clear.
`
`9. Suspend the pellet in wash buffer minus the Triton X-100 and urea, using 4 to 6 ml
`buffer per gram wet cells. Centrifuge 30 min at 22,000 × g (12,000 rpm in JA-14),
`◦
`4
`C.
`
`The final wash removes excess Triton X-100 from the pellet.
`If necessary the washed pellets can be stored at −80
`◦
`C. It is better to store material at
`this stage rather than after the extraction stage (see annotation to step 13).
`Extract recombinant protein from washed pellets with guanidine·HCl
`10. Using the tissue homogenizer, suspend the pellet in guanidine·HCl-containing ex-
`traction buffer. Use 0.5 to 1.0 ml buffer per gram wet weight of original cells if the
`extract will be subjected to gel filtration, and 2 to 4 ml buffer if the extract will be
`used in protein folding procedures. Perform this step at room temperature.
`To estimate the amount of recombinant protein in the washed pellets, use the following
`guidelines. (1) An expression level of 1% corresponds to ∼1 mg recombinant protein per
`1 gwet cells. (2) The recovery of highly aggregated recombinant protein in the washed
`pellets is ∼75% that originally present in the cells. (3) About 60% of the total washed
`pellet protein is recombinant-derived. Thus, if 50 g cells is processed and the expression
`level is 5%, the washed pellets contain ∼200 mg recombinant protein.
`The total amount of recombinant-derived protein in washed pellets can be directly deter-
`mined by measuring the total protein concentration or by analyzing the washed pellets
`via SDS-PAGE (see Support Protocol and UNIT 10.1) todetermine the proportions of the
`protein constituents.
`
`For gel-filtration purposes, the pellets from 50 g wet weight E. coli cells are solubilized
`with 40 to 50 ml extraction buffer (see Basic Protocol 2); the concentration of recombinant
`protein in the extract will be 4 to 5 mg/ml. For direct protein folding (UNIT 6.5), the
`pellets are extracted with 100 to 200 ml buffer, and the concentration of recombinant
`protein 1 to 2 mg/ml. If the washed pellet is heavily contaminated with outer cell wall and
`peptidoglycan material, the extract must be diluted further with extraction buffer (usually
`1:1 to 1:3) to reduce the viscosity before it can be used for chromatography.
`11. Centrifuge the suspension 1 hr at 100,000× g (30,000 rpm in 45 Ti rotor in a Beckman
`◦
`Optima XL-90 ultracentrifuge), 4
`C.
`For volumes <250 ml the Beckman 70 Ti rotor (capacity 6 × 39 ml) can be used at 32,000
`rpm (−100,000 × g).
`12. Carefully pour off the supernatant from the pellet. Filter the supernatant through a
`0.22-µm syringe filter attached to a 20-ml disposable syringe.
`
`The filter removes unpelleted large cell wall debris that will clog most chromatography
`columns.
`
`13. Use the clarified inclusion body extract for preparing folded protein (UNIT 6.5) or
`purify further by gel filtration (see Basic Protocol 2).
`
`Current Protocols in Protein Science
`
`Purification of
`Recombinant
`Proteins
`
`6.3.3
`
`Supplement 38
`
`Page 3
`
`

`

`Nickel-chelate affinity chromatography can also be directly used for His-tagged proteins
`(see Commentary in this unit and Basic Protocol 3 in UNIT 6.5).
`The extract can be stored at −80
`◦
`C until required. Freeze in plastic (or polyethylene)
`containers rather than glass. Divide sample into 10- to 20-ml aliquots instead of freezing
`in one large lot and fill containers to only 50% to 75% capacity.
`
`MEDIUM-PRESSURE GEL-FILTRATION CHROMATOGRAPHY IN THE
`PRESENCE OF GUANIDINE HYDROCHLORIDE
`Washed, extracted pellets (see Basic Protocol 1) contain >50% recombinant protein and
`are used as the starting material for purification of the protein of interest by gel-filtration
`chromatography. Superdex 200 gel-filtration medium, which allows high flow rates, is
`◦
`washed and packed into a column. The column is equilibrated at 4
`C and the sample is
`applied.
`
`Assay of column fractions by gel electrophoresis in the presence of SDS is complicated by
`the fact that guanidine·HCl forms a precipitate with SDS. Therefore, preparing samples
`for gel analysis involves selective precipitation of protein from guanidine·HCl prior to
`SDS-PAGE (see Support Protocol). The purified (or partially) purified protein is used as
`the starting material for procedures (e.g., UNIT 6.5) inwhich the denatured protein is folded
`into a native and biologically active structure.
`
`Materials
`
`Gel-filtration medium: Superdex 200 PG (preparative grade; Amersham
`Biosciences)
`5% (v/v) ethanol
`Gel-filtration buffer (see recipe)
`Guanidine·HCl extract of E. coli cells containing the protein of interest (see Basic
`Protocol 1)
`4- to 6-liter plastic beaker
`Chromatography column: Amersham Biosciences XK 16/100, 26/100, or 50/100
`Packing reservoir: Amersham Biosciences RK 16/26 (for 16- and 26-mm-i.d.
`columns) and RK 50 (for 50-mm-i.d. column)
`Chromatography pump: Amersham Biosciences P-6000 or P-500
`Injection valve (to select between sample loop and pump)
`UV monitor and fraction collector
`Sample loop (volume determined by size of column; also see annotation to step 15)
`
`NOTE: The various components of the chromatography system (pumps, valves, mon-
`itors, and sample loops) listed separately above are supplied as components of the
`¨AKTAexplorer chromatography system (Amersham Biosciences), which is used to run
`the XK 50/100 column. The smaller XK columns (2.6 and 2.5 cm i.d.) are run using
`the ¨AKTA-FPLC chromatography system (also from Amersham Biosciences), which is
`designed for small- to medium-scale work. For further details on this equipment see the
`manufacturer’s literature (e.g., Process Products, Amersham Biosciences).
`
`NOTE: Perform steps 1 to 11 at room temperature. After the column is packed, equilibrate
`◦
`and elute at 4
`C.
`
`Pack the column
`1. Wash the gel-filtration medium in a large plastic beaker with 5% ethanol. Let the
`medium settle and adjust the volume of liquid to yield a gel slurry concentration of
`65% to 75%.
`
`Current Protocols in Protein Science
`
`BASIC
`PROTOCOL 2
`
`Preparation and
`Extraction of
`Inclusion Bodies
`
`6.3.4
`
`Supplement 38
`
`Page 4
`
`

`

`The XK 16/100, 26/100, and 50/100 columns are 100 cm long and have inner diameters
`of 16, 26, and 50 mm, respectively. Hence, for an XK 50/100 column, column volume =
`
`radius (2.5 cm)2 × 3.1416 × bed height (97 cm) ∼= 1900 ml, and ∼2 liters preparative-
`grade Superdex 200 is required. To pack this column, the gel medium is suspended in 5%
`ethanol to give a total volume of 3 liters which corresponds to ∼70% gel slurry (it should
`be noted that the RK 50 reservoir has a capacity of 1 liter, so the 3 liters of gel slurry can
`be poured in a single operation).
`
`2. Fix the chromatography column in an upright position, using a level to adjust the
`position. Attach the packing reservoir.
`
`3. Add sufficient 5% ethanol to displace the air from a few centimeters of the bottom
`of the column. Clamp off the bottom of the column.
`
`4. Gently mix the gel-filtration medium in the plastic beaker using a glass rod or plastic
`paddle to an even slurry of 70% medium suspended in 5% ethanol.
`
`Do not use a magnetic stirrer, as it could damage the medium.
`
`5. Degas the suspension 5 to 10 min using a vacuum flask and laboratory vacuum.
`
`The ethanol is included to reduce the surface tension and density of the solvent, thus
`allowing air bubbles that form to rise to the surface more quickly.
`
`6. Carefully pour the slurry of medium into the column, introducing material along the
`side of the column to avoid creating air bubbles.
`
`7. Let the column stand 5 min and then unclamp the bottom of the column.
`
`8. Attach the chromatography pump to the packing reservoir and pump 5% ethanol
`(degassed) into the column at an appropriate flow rate (based on manufacturer’s
`instructions). Pack the column at a pressure greater than the pressure at which the
`column will be run (up to twice as high), but not greater than the maximum pressure
`rating of the column.
`For example, the XK 50/100 column (rated to 0.5 MPa) is packed at ∼20 to 30 ml/hr and
`∼0.4 MPa.
`9. After the medium has settled, turn off the pump and close the bottom of the column.
`Pipet fluid from the reservoir and remove the reservoir.
`
`Once the column has been packed, be careful to prevent air from entering the column bed.
`Air will disturb the bed and reduce the column separation resolution.
`
`10. Attach the column top adapter to the column. Place the top of the adapter onto the
`top of the packed medium and gently compress the medium.
`
`11. Reattach the pump to the column and wash the column with water at a flow rate that
`will generate the maximum pressure to be used. If the medium continues to settle,
`readjust the top adapter to maintain a firm fit against the gel.
`◦
`
`From this point onward, perform all steps at 4
`
`C.
`
`Equilibrate the column
`◦
`12. Equilibrate the column with at least 1 column volume of 4
`C gel-filtration buffer.
`Although the proteins were extracted with buffer containing 8 M guanidine·HCl (see Basic
`Protocol 1), the gel-filtration buffer contains only 4 M guanidine·HCl. The concentration
`is reduced to allow faster flow rates and for reasons of economy. Most proteins remain
`unfolded at the lower guanidine·HCl concentration. If, however, the protein elutes in an
`anomalous manner (e.g., in more than one peak or at an elution position not consistent
`with its size), and assuming there is adequate reducing agent present, then try increasing
`the guanidine·HCl concentration in the gel-filtration buffer.
`
`Current Protocols in Protein Science
`
`Purification of
`Recombinant
`Proteins
`
`6.3.5
`
`Supplement 38
`
`Page 5
`
`

`

`13. Measure the actual flow rate while running the column at a flow rate that generates
`a back pressure about one-half of that generated when packing the column (step 8).
`
`For an XK50/100 column packed using Superdex 200 at 0.4 MPa, a running pressure of
`∼0.2 MPa is used, which generates flow rates of 5 to 10 ml/min that are equivalent to linear
`flow rates of 15.3 to 30.6 cm/hr. The linear flow rate equals the flow rate (ml/hr)/cross-
`sectional area (cm2). At these flow rates it takes between 3 and 6 hr to complete the
`chromatography.
`
`14. Connect tubing from the end of the column to the UV monitor and the fraction
`collector.
`
`Apply the sample
`15. Load the sample loop with the guanidine·HCl extract to be separated.
`Avoid loading a sample volume >5% of the total column volume; the optimum sample size
`is 2% (∼40 ml for the XK 50/100 column). The sample consists of washed pellets extracted
`with guanidine·HCl (see Basic Protocol 1). A sample size of 40 to 50 ml is usually derived
`from ∼50 g wet weight cells. With smaller sample sizes, use columns with proportionally
`smaller diameters (e.g., XK 16/100 or 26/100 columns). If purchase of only one column
`is possible, a 2.5 × 100–cm size is a good compromise for variable sample loading.
`16. Monitor column effluent with the UV monitor and collect fractions with the fraction
`collector.
`For an XK50/100 column, collect 15- to 20-ml fractions in 16 × 20–mm culture tubes.
`The eluent from the column is usually monitored at 280 nm or, if the protein has a par-
`ticularly low extinction coefficient, at 230 nm (guanidine·HCl strongly absorbs below
`225 nm). For an XK 50/100 column, fractions need only be collected after ∼500 ml of
`elution. The excluded volume (void volume) is ∼570 ml. Run a total of one column volume
`(1900 ml) to ensure all of the load material is eluted from the column.
`
`17. Prepare the fractions to be assayed for SDS-PAGE (see Support Protocol and UNIT 10.1).
`
`SUPPORT
`PROTOCOL
`
`PREPARATION OF SAMPLES CONTAINING GUANIDINE
`HYDROCHLORIDE FOR SDS-PAGE
`Because guanidine·HCl forms a precipitate with SDS, it is necessary to remove the
`former before carrying out SDS-PAGE. Protein in column fractions is separated from
`guanidine·HCl by precipitation using 90% ethanol (Pepinsky, 1991).
`
`Materials
`
`Sample containing the protein of interest
`◦
`◦
`to 4
`C
`100% and 90% ethanol, 0
`1× SDS sample buffer (UNIT 10.1)
`Gilson Pipetman (Rainin Instrument)
`Additional reagents and equipment for gel electrophoresis (UNIT 10.1)
`
`1. Pipet 25 µl sample containing the protein of interest into a 1.5-ml microcentrifuge
`tube.
`
`to 4
`
`C) 100% ethanol to the sample in the tube.
`
`◦
`2. Add 225 µl cold (0
`
`◦
`
`Preparation and
`Extraction of
`Inclusion Bodies
`
`6.3.6
`
`Supplement 38
`
`The final ethanol concentration is 90% by volume.
`3. Mix the sample and ethanol by vortexing. Chill 5 to 10 min at −20
`◦
`−80
`◦
`C).
`Do not use a magnetic stirrer, as it could damage the medium.
`
`C orcolder (e.g.,
`
`Current Protocols in Protein Science
`
`Page 6
`
`

`

`4. Microcentrifuge the sample 5 min at maximum speed (∼15,000 × g), 4
`◦
`withdraw the supernatant and retain the pellet.
`
`C. Carefully
`
`The pellet may be difficult to see. Be careful not to draw the pellet out of the microcentrifuge
`tube with the supernatant.
`
`5. Suspend the pellet in 250 µl cold 90% (v/v) ethanol. Mix thoroughly using a vortex
`mixer.
`
`The 90% ethanol is prepared by mixing 225 µl ethanol and 25 µl H2O.
`◦
`6. Microcentrifuge the sample 5 min at maximum speed, 4
`C. Carefully pipet off the
`supernatant and suspend the pellet in 25 µl of 1× SDS sample buffer.
`Some proteins are more difficult than others to suspend from an ethanol precipitate.
`Electrophoresis sample buffer containing 8 M urea is helpful for such proteins (UNIT 10.1).
`Sonication with a microtip probe can also be used to disperse the sample. A volume of
`sample buffer >25 µl may be required in this case (e.g., 50 µl), and great care must be
`taken to prevent foaming of the sample caused by excessive sonication power.
`◦
`◦
`
`7. Heat the sample 3 to 5 min at 90
`(UNIT 10.1).
`
`to 100
`
`C. Load on an SDS-polyacrylamide gel
`
`REAGENTS AND SOLUTIONS
`Use Milli-Q-purified water or equivalent in all recipes and protocol steps. For common stock
`solutions, see APPENDIX 2E; for suppliers, see SUPPLIERS APPENDIX.
`
`Extraction buffer
`50 mM Tris·Cl, pH 7.0
`5 mMEDTA
`8 Mguanidine·HCl (764 g/liter)
`5 mMDTT (770 mg/liter)
`If the buffer is cloudy, filter through a 0.45- to 0.5-µm filter (the solution
`should be clear if high-quality guanidine·HCl—e.g., ultrapure grade, ICN
`Biomedicals—is used; see APPENDIX 3A). Buffer can be stored without DTT for
`◦
`C.
`at least 1 month at 4
`
`Gel-filtration buffer
`50 mM Tris·Cl, pH 7.5
`4 Mguanidine·HCl (382 g/liter; ultrapure, Invitrogen Life Technologies)
`5 mMDTT (770 mg/liter)
`◦
`C. Filter (as for
`Buffer can be stored without DTT at least 1 month at 4
`extraction buffer; see recipe) and degas before use.
`Higher concentrations of guanidine·HCl (up to 8 M) may be required for some proteins
`(see annotation at step 12 of Basic Protocol 2).
`
`Lysis buffer
`100 mM Tris·Cl, pH 7.0
`5 mMEDTA
`5 mMDTT (770 mg/liter)
`5 mMbenzamidine·HCl (780 mg/liter)
`Prepare immediately before use
`The Tris·Cl and EDTA are diluted from concentrated stock solutions. The other compo-
`nents are added to the diluted buffer before use.
`
`Current Protocols in Protein Science
`
`Purification of
`Recombinant
`Proteins
`
`6.3.7
`
`Supplement 38
`
`Page 7
`
`

`

`Wash buffer
`100 mM Tris·Cl, pH 7.0
`5 mMEDTA
`5 mMDTT (770 mg/liter)
`2 Murea (120 g/liter; ultrapure, Invitrogen Life Technologies)
`2% (w/v) Triton X-100 (20 g/liter; Calbiochem)
`
`Add DTT, urea, and Triton X-100 to the other components immediately before use.
`Prepare this buffer in two forms: one with and one without the urea and Triton
`X-100 (the latter for use in Basic Protocol 1, step 9).
`
`COMMENTARY
`Background Information
`The decision of whether to work with in-
`soluble recombinant protein or to put more ef-
`fort into generating soluble protein (e.g., by
`modifying the expression vector, changing the
`host strain and fermentation conditions, or co-
`expressing chaperones) can be dictated by the
`nature of the protein. A small protein (10 to
`17 kDa) with only one or two cysteine residues
`might be expected to fold in reasonable yield
`from extracted inclusion bodies. Larger pro-
`teins (>25 kDa) with many cysteine residues
`may be more problematic, and lower folding
`yields can normally be expected. In the lat-
`ter case, if only small amounts of material are
`needed then yield is not such an important
`issue.
`It should be emphasized that, unless proved
`otherwise, a protein folded from insoluble in-
`clusion bodies can be expected to have the
`same structural and conformational integrity
`as the same protein directly purified from sol-
`uble extracts (also see UNIT 6.1). It is similarly
`true that a purified soluble protein can be dena-
`tured and renatured (reversible denaturation)
`without structural or conformational modifi-
`cations (reviewed by Anfinson, 1973; Fersht,
`1999; and Pain, 2001).
`Basic Protocol 1 describes the prepara-
`tion of inclusion bodies suitable for extrac-
`tion purposes. The insoluble protein is washed
`in buffers containing various additives by sus-
`pension and low-speed centrifugation. The re-
`sultant washed pellets (inclusion bodies), al-
`though highly enriched in the recombinant pro-
`tein (Figure 6.3.1), are still contaminated with
`bacterial proteins, lipids, and nucleic acids.
`This is not an issue if the protein is going
`to be partially purified, e.g., by gel filtration
`(Basic Protocol 2) prior to folding. However,
`if the solubilized protein is going to be di-
`rectly used in folding scenarios, there may
`be an advantage in further purifying the in-
`clusion bodies, as the bacterial contaminants,
`
`especially the nonproteinacous ones, may in-
`fluence protein folding (Darby and Creighton,
`1990; Maachupalli-Reddy et al., 1997). Inclu-
`sion bodies have also been purified from bac-
`terial lysates by sucrose step-gradient centrifu-
`gation (Georgiou and Valax, 1999).
`
`How inclusion bodies are formed
`Inclusion bodies are noncrystalline, amor-
`phous structures; however, there is some ev-
`idence that the constituent densely packed
`proteins may have native-like secondary struc-
`tures (Oberg et al., 1994). This suggests that
`the aggregates are formed by the association
`of partially folded protein or misfolded pro-
`tein. Folded subdomains could presumably as-
`sociate with complementary binding surfaces
`in an intermolecular manner to form oligomers
`and eventually aggregates (Fink, 1998). Dur-
`ing in vitro folding studies with a mixture of
`proteins, folding intermediates do not coaggre-
`gate with each other, but only with themselves.
`This indicates that aggregation occurs by spe-
`cific interaction of certain conformations of
`folding intermediates rather than by nonspe-
`cific coaggregation, providing a rationale for
`recovering relatively pure protein from the in-
`clusion body state (Speed et al.,1996).
`The propensity of a protein to form inclu-
`sion bodies does not appear to be directly re-
`lated to the presence of sulfhydryl residues,
`as proteins without sulfhydryls still form such
`aggregates. It has been found that aggregates
`derived from proteins that in their native state
`contain disulfides consisting mainly of re-
`duced protein (Langley et al., 1987). The re-
`duction of disulfides in native proteins can
`dramatically reduce their solubility and even
`result in unfolding. Hence the reducing envi-
`ronment of E. coli may contribute to the in-
`stability and low solubility of these types of
`protein. Once the protein has been solubilized,
`reducing agents must be included to prevent
`the formation of nonnative disulfide bonds.
`
`Current Protocols in Protein Science
`
`Preparation and
`Extraction of
`Inclusion Bodies
`
`6.3.8
`
`Supplement 38
`
`Page 8
`
`

`

`Figure 6.3.1 Analysis by SDS-PAGE of fractions from low-speed centrifugation of E. coli cell
`lysates containing aggregated bovine growth hormone. A 12.5% acrylamide gel of dimensions
`12 cm × 16 cm × 1.5 mm was used with the Laemmli buffer system (UNIT 10.1). Lanes a and g
`contain molecular weight standards (low-range standards, Bio-Rad) in order of increasing migration
`distance: phosphorylase b (97.4 kDa), bovine serum albumin (66.2 kDa), hen egg white ovalbumin
`(45 kDa), bovine carbonic anhydrase (31 kDa), soybean trypsin inhibitor (21.5 kDa), and hen egg
`white lysozyme (14.4 kDa). After low-speed centrifugation of the clarified lysate and of the washed
`pellet homogenate (see Basic Protocol 1, steps 5 and 7), the supernatants will be cloudy (lane f)
`and the pellets usually consist of two layers (see Fig. 6.1.5). The bottom layer is inclusion body
`protein plus unbroken cells (lanes b and c) and the top layer consists of outer membrane and
`peptidoglycan fragments (lanes d and e). The outer membrane proteins OmpA (35 kDa) and
`OmpF/C (38 kDa) are indicated by ; and o, respectively. After the washing steps, the growth
`hormone (marked β, 21kDa) is the major constituent (lanes h and i) together, in this example, with
`another plasmid-encoded protein, namely kanamycin phosphotransferase (marked α, 30.8 kDa),
`the product of the gene conferring resistance to the antibiotic kanamycin.
`
`Some of the other factors that may con-
`tribute to aggregate formation include: lack
`of post-translational modification (especially
`glycosylation), lack of access to chaperones,
`and enzymes catalyzing folding (e.g., cis-trans
`isomerase) and the very high concentration of
`protein coupled with limited solubility of fold-
`ing intermediates.
`Although inclusion body formation and its
`prevention are of great academic and commer-
`cial interest, the pragmatic situation is clearly
`summarized by Seckler and Jaenicke (1992),
`who state: “That inclusion bodies are aggre-
`gates of otherwise intact polypeptides in non-
`nativelike conformations has been proven re-
`peatedly by the successful refolding of active
`proteins after dissociation of the aggregates by
`chemical dissociation.” It must be noted that
`the work of Oberg et al. (1994) does not in-
`
`validate this statement. It is simply a matter
`of terminology: the protein in aggregates may
`have nativelike secondary structures, but com-
`pared with soluble folded protein it must still
`be considered nonnative.
`
`Extracting inclusion body protein
`Proteins are extracted from inclusion bod-
`ies using strong protein denaturants. Protein
`denaturation can be induced by the following
`solvent conditions or reagents.
`1. pH. Protein denaturation occurs because
`of the ionization of side chains. Generally, pro-
`teins retain less residual structure (are more
`denatured) when exposed to high pH (e.g.,
`>10.5) compared to low pH (<4.5). Acidic
`or basic pH may be used in conjunction with
`urea or inorganic salts. An example of acidic
`pH extraction is given in UNIT 6.5.
`
`Current Protocols in Protein Science
`
`Purification of
`Recombinant
`Proteins
`
`6.3.9
`
`Supplement 38
`
`Page 9
`
`

`

`Table 6.3.1 Gel-Filtration Matrices Suitable for Use with Solutions Containing Guanidine
`Hydrochloride
`
`Matrixa
`
`Mass range (kDa)
`Native proteins Unfolded proteinsb
`
`Reference
`
`Mann and Fish (1972)
`1-80
`10-4,000
`Sepharose CL-6B
`Mann and Fish (1972)
`1-80
`10-5,000
`Bio-Gel A-5m
`Mann and Fish (1972)
`10-300
`60-20,000
`Sepharose CL-4B
`<1-30 c
`1-100
`Sephacryl S-100 HR
`—
`Belew et al. (1978)
`1-50
`5-250
`Sephacryl S-200 HR
`1-100 c
`10-1,500
`Sephacryl S-300 HR
`—
`1->100 c
`20-8,000
`Sephacryl S-400 HR
`—
`I.P. and P.T.W. (unpub. observ.)
`<1-25
`3-70
`Superdex 75
`I.P. and P.T.W. (unpub. observ.)
`1-80
`10-600
`Superdex 200
`aAll resins are from Amersham Biosciences except Bio-Gel A-5m, which is from Bio-Rad. The Sepharose and Bio-Gel
`matrices are normally run under low pressure; all other resins can be run under low or medium pressure. Medium pressure
`is achieved using one of the chromatography pumps indicated in Basic Protocol 2; the pumps are normally included in
`the Amersham Biosciences ¨AKTA-FPLC or ¨AKTAexplorer systems.
`bData on the fractionation range in the unfolded state refer to proteins unfolded with guanidine·HCl; however,the
`guidelines also apply to proteins unfolded and eluted with urea (assuming they are random coils).
`cEstimates based on fractionation range for native proteins.
`
`2. Organic solvents. Examples of organic
`solvents include ethanol and propanol. Gen-
`erally, proteins are not completely unfolded
`in these solvents. Organic solvents are infre-
`quently used for the primary extraction of in-
`clusion bodies but can be useful cosolvents to
`enhance protein folding (see Table 1 in De
`Bernardez Clark, et al., 1999 and references
`cited therein).
`3. Organic solutes. Examples of organic so-
`lutes include guanidine·HCl (used at 6 to 8
`M) and urea (used at 6 to 9 M). The effec-
`tiveness of urea is modulated by pH and ionic
`strength, whereas that of guanidine is not. Both
`solutes are more effective at elevated temper-
`atures (see additional discussion of tempera-
`ture under point 6, below). Organic solutes are
`the most versatile and most commonly used
`denaturants for solubilizing inclusion bodies.
`The denaturing power of guanidinium salts in-
`−− < Br− < I− < SCN
`
`
`
`creases in the order Cl
`.
`4. Detergents. The most common ex-
`amples of protein-denaturing detergents are
`sodium dodecyl sulfate (SDS, an anionic deter-
`gent) and cetyltrimethylammonium bromide
`(CTAB, a cationic detergent). SDS is a very ef-
`fective protein denaturant, as it directly binds
`to the protein However, it should be used with
`caution to solubilize inclusion bodies, as it
`can interfere with the recovery folded pro-
`tein in reasonable yields (see, e.g., van Kim-
`menade et al., 1988). Solubilization with the
`
`anionic detergent N-lauroylsarcosine (Sarko-
`syl) has been used to effectively extract inclu-
`sion body protein with subsequent successful
`protein folding (Nguyen et al., 1993; Burgess
`and Knuth, 1996). Sarkosyl, with a critical
`micelle concentration

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket